Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?

McBride A., Mehta P., Rivino L., Ramanan AV., Yacoub S.

DOI

10.1016/s2666-5247(21)00087-2

Type

Journal

The Lancet. Microbe

Publication Date

07/2021

Volume

2

Pages

e277 - e278

Addresses

Department of Global Health and Infection, Brighton and Sussex Medical School, Brighton, UK; Oxford University Clinical Research Unit, Ho Chi Minh City 70000, Vietnam.

Keywords

Humans, Dengue, Droughts, COVID-19, SARS-CoV-2

Permalink Original publication